Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
Abstract Introduction Infliximab infusion generally occurs in 2–4 h. Recent studies have suggested the possibility of accelerated infusion (1 h) of this drug. Objective To evaluate the safety of accelerated infliximab infusion in patients with rheumatic diseases. In addition, patient satisfaction wa...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2018-08-01
|
| Серія: | Advances in Rheumatology |
| Предмети: | |
| Онлайн доступ: | http://link.springer.com/article/10.1186/s42358-018-0016-x |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|